OncoCyte Corporation (OCX) declined -5.6% or -0.14 to $2.36. It is approximately 12648 shares traded, which is 26.26% compare to the average total volume 48165. The market cap of OCX is $95.97 million. The year to date change is -51.25%. The 52 week price range is from $1.1 to $7.09. Price of OCX have changed 0.00% during last week. It have changed 4.17% over last month, -5.66% over last 3 months, 25.00% over last 6 months and -59.02% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OCX is 2.43. It is 2.97% above current price. The 200-day Moving Averages for OCX is 2.87. It is 21.61% above current price. The 52-week High is 7.09. It is 200.42% from the current price. The 52-week Low is 1.1. It is -53.39% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of OCX is 12.7 on 2018-09-14. Short % to float is 2.06%. There are some statistics of OCX. It is has market cap $95.97 million. The share outstanding is 40.66 million. The average volume is 48165. It has 12.03M cash and 2.60M in debt. The percent of top 15 Institution holding is 21.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OCX is -303.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OCX is -155.61%.